Skip to main content Accessibility help
×
Hostname: page-component-848d4c4894-pjpqr Total loading time: 0 Render date: 2024-06-26T02:22:25.105Z Has data issue: false hasContentIssue false

47 - Schistosomiasis

from Section 8 - Helminth infections

Published online by Cambridge University Press:  05 March 2013

David Mabey
Affiliation:
London School of Hygiene and Tropical Medicine
Geoffrey Gill
Affiliation:
University of Liverpool
Eldryd Parry
Affiliation:
Tropical Health Education Trust
Martin W. Weber
Affiliation:
World Health Organization, Jakarta
Christopher J. M. Whitty
Affiliation:
London School of Hygiene and Tropical Medicine
Get access

Summary

Schistosomiasis is the generic name given to diseases caused by parasitic blood flukes of the genus Schistosoma. An older name, still widely used in Africa, is bilharzia. Of the three major species that commonly infect humans, two occur predominantly in Africa:

  • S. mansoni, a cause of intestinal schistosomiasis, also found in Brazil and the Caribbean; and

  • S. haematobium, the cause of urinary schistosomiasis, also found in the Middle East.

The third major species, S. japonicum, causes another form of intestinal schistosomiasis but is found only in the Far East. A minor species, S. intercalatum, causes infection but insignificant disease in small areas of Central Africa.

Schistosomiasis is typically a chronic infection. Adult worms slowly accumulate from early childhood over a period of 10 to 20 years, and the deposition of eggs in the tissues leads to fibrosis in the intestines and liver (S. mansoni) or the urinary tract (S. haematobium). Mild or moderate symptoms occur in most infected children: severe disease develops in later life in only a minority of these individuals. For detailed reviews of different aspects, the reader is referred to books edited by Jordan et al. (1993) and Mahmoud (2001).

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2013

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Brooker, S, Kabatereine, NB, Gyapong, JO et al. (2009a). Rapid mapping of schistosomiasis and other neglected tropical diseases in the context of integrated control programmes in Africa. Parasitology; 136: 1707–18.CrossRefGoogle ScholarPubMed
Brooker, S, Kabatereine, NB, Smith, JL et al. (2009b). An updated atlas of human helminth infections: the example of East Africa. Int J Health Geographics; 8: 42–52.CrossRefGoogle ScholarPubMed
Chevillard, C, Moukoko, CE, Elwali, NE et al. (2003). IFN-gamma polymorphisms (IFN-gamma +2109 and IFN-gamma +3810) are associated with severe hepatic fibrosis in human hepatic schistosomiasis (Schistosoma mansoni). J Immunol; 171: 5596–601.CrossRefGoogle Scholar
Doenhoff, MJ, Hagan, P, Cioli, D et al. (2009). Praziquantel: its use in control of schistosomiasis in sub-Saharan Africa and current research needs. Parasitology; 136: 1825–35.CrossRefGoogle ScholarPubMed
Doumenge, JP, Mott, KE, Cheung, C et al. (1987). Atlas of the Global Distribution of Schistosomiasis. Geneva: World Health Organization Talence: Presses Universitaires de Bordeaux. 400 pp.Google Scholar
Fenwick, A, Webster, JP, Bosque-Oliva, E et al. (2009). The Schistosomiasis Control Initiative (SCI): rationale, development and implementation from 2002–2008. Parasitology; 136: 1719–30.CrossRefGoogle ScholarPubMed
Fleming, FM, Fenwick, A, Tukahebwa, EM et al. (2009). Process evaluation of schistosomiasis control in Uganda, 2003 to 2006: perceptions, attitudes and constraints of a national programme. Parasitology; 136: 1759–69.CrossRefGoogle ScholarPubMed
Hotez, PJ, Fenwick, A (2009). Schistosomiasis in Africa: an emerging tragedy in our new global health decade. PLoS Negl Trop Dis; 3: 1–3.CrossRefGoogle ScholarPubMed
INSERM. (2009). Development of a therapeutic schistosomiasis vaccine. , English version available at the site.
Jordan, P, Webbe, G, Sturrock, RF, eds. (1993). Human Schistosomiasis. Wallingford, UK: CAB International, 465 pp.
Kabatereine, NK, Vennervald, BJ, Ouma, JH et al. (1999). Adult resistance to schistosomiasis mansoni: age-dependence of reinfection remains constant in communities with diverse exposure patterns. Parasitology; 118: 101–5.CrossRefGoogle ScholarPubMed
Kallestrup, P, Zinyama, R Gomo et al. (2005). Schistosomiasis and HIV-1 infection in rural Zimbabwe: effect of treatment of schistosomiasis on CD4 cell count and plasma HIV-1 RNA load. J Infect Dis; 192: 1956–61.CrossRefGoogle ScholarPubMed
King, CH, Dickman, K, Tisch, DJ (2005). Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis. Lancet; 365: 1561–69.CrossRefGoogle ScholarPubMed
Kjetland, EF, Ndhlovu, PD, Gomo, E et al. (2006). Association between genital schistosomiasis and HIV in rural Zimbabwean women. AIDS; 20: 593–600.CrossRefGoogle ScholarPubMed
Koukounari, A, Sacko, M, Keita, A et al. (2006). Assessment of ultrasound morbidity indicators of schistosomiasis in the context of large-scale programs illustrated with experiences from Malian children. Am J Trop Med Hyg; 75: 1042–52.Google ScholarPubMed
Mahmoud, AAF. (ed.). (2001). Schistosomiasis. Tropical Medicine. Science and Practice; Vol 3. ed. Pasvol, G, Hoffman, SL. London: Imperial College Press. 550 pp.Google Scholar
McManus, DP, Loukas, A (2008). Current status of vaccines for schistosomiasis. Clin Microbiol Rev; 21: 225–42.CrossRefGoogle ScholarPubMed
Ouma, JH, King, CH, Muchiri, EM et al. (2005). Late benefits 10–18 years after drug therapy for infection with Schistosoma haematobium in Kwale District, Coast Province, Kenya. Am J Trop Med Hyg; 73: 359–64.Google ScholarPubMed
Poggensee, G, Kiwelu, I, Weger, V et al. (2000). Female genital schistosomiasis of the lower genital tract: prevalence and disease-associated morbidity in northern Tanzania, J Inf Dis; 181: 1210–13.CrossRefGoogle ScholarPubMed
Richter, J, Hatz, C, Campagne, G et al. (2000). Ultrasound in schistosomiasis: a practical guide to the standardized use of ultrasonography for the assessment of schistosomiasis-related morbidity. World Health Organization, Geneva, .Google Scholar
Simoonga, C, Utzinger, J, Brooker, S et al. (2009). Remote sensing, geographical information system and spatial analysis for schistosomiasis epidemiology and ecology in Africa. Parasitology; 136: 1683–93.CrossRefGoogle ScholarPubMed
Steinmann, P, Keiser, J, Bos, R et al. (2006). Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk. Lancet Infectious Diseases; 6: 411–25.CrossRefGoogle ScholarPubMed
Stothard, JR, Chitsulo, L, Kristensen, TK, Utzinger, J (2009). Control of schistosomiasis in sub-Saharan Africa: progress made, new opportunities and remaining challenges. Parasitology; 136: 1665–75.CrossRefGoogle ScholarPubMed
Utzinger, J, Raso, G, Brooker, S et al. (2009). Schistosomiasis and neglected tropical diseases: towards integrated and sustainable control and a word of caution. Parasitology; 136: 1859–74.CrossRefGoogle Scholar
Van Dam, GJ, Wichers, JH, Ferreira, TM et al. (2004). Diagnosis of schistosomiasis by reagent strip test for detection of circulating cathodic antigen. J Clin Microbiol; 42: 5458–61.CrossRefGoogle ScholarPubMed
Van der Werf, MJ, de Vlas, SJ, Brooker, S et al. (2003). Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa. Acta Trop; 86: 125–39.CrossRefGoogle ScholarPubMed
Wilson, S, Vennervald, BJ, Kadzo, H et al. (2007). Hepatosplenomegaly in Kenyan schoolchildren: exacerbation by concurrent chronic exposure to malaria and Schistosoma mansoni infection. Trop Med Int Hlth; 12: 1442–9.CrossRefGoogle ScholarPubMed
Wilson, S, Jones, FM, Mwatha, JK et al. (2008). Hepatosplenomegaly is associated with low regulatory and Th2 responses to schistosome antigens in childhood schistosomiasis and malaria coninfection. Infect Immun; 76: 2212–18.CrossRefGoogle Scholar
World Health Organization (2002). Report of the WHO informal consultation on the use of praziquantel during pregnancy/lactation and albendazole/mebendazoles in children under 24 months. WHO/CDS/OVC/2002.4: Geneva. .Google Scholar
World Health Organization (2006). Preventive chemotherapy in human helminthiasis. ISBN 92 4 1547103.

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×